MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading

FRIDAY, March 31, 2023 (HealthDay News) — Cats constantly licking and chewing because of a skin condition called feline allergic dermatitis may benefit from a new generic treatment approved by the U.S. Food and Drug Administration. The FDA approved Modulis for Cats on March 29, making it the first genericContinue Reading

TUESDAY, March 28, 2023 (HealthDay News) — Researchers have discovered that two drugs might be better than one for women who have advanced endometrial cancer. Combining chemotherapy and immunotherapy or a monoclonal antibody at the same time helped these patients live longer without their cancer progressing, especially those who hadContinue Reading

MONDAY, March 20, 2023 (HealthDay News) — In more bad news about antibiotic resistance, new research suggests that people and their pets may be able to transmit multidrug-resistant germs to each other. Still, cases of cross-transmission are rare and it’s not clear if pets are giving germs to people orContinue Reading

SATURDAY, Feb. 25, 2023 (HealthDay News) — Causes of different kinds of dementia vary, but about 40% are affected by risk factors a person can influence through lifestyle choices. Two University of Michigan neurologists offer 10 tips for modifying those risks. Keep blood pressure in check. Dr. Judith Heidebrink, aContinue Reading

FRIDAY, Feb. 24, 2023 (HealthDay News) — The U.S. Food and Drug Administration’s heavily criticized tobacco program promised changes on Friday, including a five-year strategic plan to better outline priorities. “As we enter this era of declining use of combustible tobacco and continued innovation in the e-cigarette industry, the societalContinue Reading